BioLineRX Ltd
N/A
USD
N/A
N/A
...
Chart
Financials
Description
BLRX Company Description
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
BLRX Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view BLRX Smart Score
Score Breakdown
BLRX Company Description
Show More
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of BLRX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by BLRX's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of BLRX in WallStreetBets Daily Discussion
BLRX News
Recent insights relating to BLRX
CNBC Recommendations
Recent picks made for BLRX stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in BLRX
Corporate Flights
Flights by private jets registered to BLRX
Our Analysis